Guilan Quan

6.0k total citations · 4 hit papers
102 papers, 4.9k citations indexed

About

Guilan Quan is a scholar working on Pharmaceutical Science, Molecular Biology and Biomedical Engineering. According to data from OpenAlex, Guilan Quan has authored 102 papers receiving a total of 4.9k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Pharmaceutical Science, 26 papers in Molecular Biology and 26 papers in Biomedical Engineering. Recurrent topics in Guilan Quan's work include Advancements in Transdermal Drug Delivery (39 papers), Nanoplatforms for cancer theranostics (25 papers) and Advanced Drug Delivery Systems (19 papers). Guilan Quan is often cited by papers focused on Advancements in Transdermal Drug Delivery (39 papers), Nanoplatforms for cancer theranostics (25 papers) and Advanced Drug Delivery Systems (19 papers). Guilan Quan collaborates with scholars based in China, United States and Canada. Guilan Quan's co-authors include Chuanbin Wu, Xin Pan, Yixian Zhou, Boyi Niu, Ting Wen, Chao Lü, Kaixin Liao, Minglong Chen, Biyuan Wu and Ying Sun and has published in prestigious journals such as SHILAP Revista de lepidopterología, ACS Nano and Biomaterials.

In The Last Decade

Guilan Quan

98 papers receiving 4.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Application of glutathione depletion in cancer therapy: Enhanced ROS-based therapy, ferroptosis, and chemotherapy

2021 854 citations Boyi Niu, Kaixin Liao et al. profile →
Mesoporous silica nanoparticles for drug and gene delivery

2018 542 citations Yixian Zhou, Guilan Quan et al. Acta Pharmaceutica Sinica B profile →
Photodynamic therapy for cancer: mechanisms, photosensitizers, nanocarriers, and clinical studies

2024 61 citations Chuanbin Wu, Zhengwei Huang et al. profile →
Gas-propelled anti-hair follicle aging microneedle patch for the treatment of androgenetic alopecia

2025 14 citations Chao Lü, Guilan Quan et al. profile →

Peers

Countries citing papers authored by Guilan Quan

Since Specialization

Citations

This map shows the geographic impact of Guilan Quan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guilan Quan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guilan Quan more than expected).

Fields of papers citing papers by Guilan Quan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guilan Quan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guilan Quan. The network helps show where Guilan Quan may publish in the future.

Co-authorship network of co-authors of Guilan Quan

This figure shows the co-authorship network connecting the top 25 collaborators of Guilan Quan. A scholar is included among the top collaborators of Guilan Quan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guilan Quan. Guilan Quan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Autonomous drug delivery and scar microenvironment remodeling using micromotor-driven microneedles for hypertrophic scars therapy 2025 ·Acta Pharmaceutica Sinica B ·Ting Wen, Yànpíng Fù, (unknown), Ying Sun, (unknown), (unknown), (unknown), Beibei Yang, Shuling Li, Chao Lü, Tingting Peng, Chuanbin Wu, Xin Pan, Guilan Quan	0
2	Dissolving microneedle-assisted in situ cancer vaccine combined with cytolytic peptide for anti-melanoma immunotherapy 2025 ·Chinese Chemical Letters ·Ying Sun, Minglong Chen, Ying Chen, (unknown), Yànpíng Fù, Zhengwei Huang, Chao Lü, Chuanbin Wu, Xin Pan, Guilan Quan	2
3	Biomineralized in situ catalytic nanoreactor integrated microneedle patch for on demand immunomodulator supply to combat psoriasis 2024 ·Theranostics ·Xiaodie Li, Minglong Chen, (unknown), (unknown), (unknown), Yànpíng Fù, Chao Lü, Chuanbin Wu, Xin Pan, Guilan Quan	5
4	Imidazole‐Rich, Four‐Armed Host‐Defense Peptidomimetics as Promising Narrow‐Spectrum Antibacterial Agents and Adjuvants against Pseudomonas Aeruginosa Infections 2024 ·Advanced Healthcare Materials ·(unknown), (unknown), (unknown), (unknown), Liqing Wang, Rui Luo, (unknown), Zejun Xu, Tingting Peng, Jianfeng Cai, Chuanbin Wu, Peng Teng, Guilan Quan, Chao Lü	3
5	Biomaterials-assisted cancer vaccine delivery: preclinical landscape, challenges, and opportunities 2024 ·Expert Opinion on Drug Delivery ·Minglong Chen, Yue Zhou, Yànpíng Fù, (unknown), Chuanbin Wu, Xin Pan, Guilan Quan	3
6	In situ polymeric nanomicelle-generating dissolving microneedle patch for enhanced transdermal methotrexate delivery in rheumatoid arthritis treatment 2024 ·European Polymer Journal ·Ting Liu, Jintao Fu, Minglong Chen, Qiaoli Wu, Guilan Quan, Chuanbin Wu, (unknown)	3
7	“On-demand” nanosystem-integrated microneedles for amplified triple therapy against recalcitrant bacteria and biofilm growth 2024 ·Materials Today Bio ·Ting Wen, Yiting Zhao, Yànpíng Fù, Ying Chen, Xiaodie Li, (unknown), Dongyi Xian, (unknown), Dan Yang, Chao Lü, Chuanbin Wu, Xin Pan, Guilan Quan	3
8	An oxygen-generating metal organic framework nanoplatform as a “synergy motor” for extricating dilemma over photodynamic therapy 2023 ·Materials Advances ·(unknown), Yixian Zhou, Biyuan Wu, Chao Lü, Guilan Quan, Zhengwei Huang, Chuanbin Wu, Xin Pan	6
9	Surface‐Engineered Vanadium Carbide MXenzyme for Anti‐Inflammation and Photoenhanced Antitumor Therapy of Colon Diseases 2023 ·Advanced Functional Materials ·Jingwen Deng, Dongyi Xian, (unknown), (unknown), (unknown), Fengyan Han, (unknown), Qing He, Guilan Quan, Chuanbin Wu, Tingting Peng, Chao Lü, Honghe Zhang	42
10	A Perfect Pair: Stabilized Black Phosphorous Nanosheets Engineering with Antimicrobial Peptides for Robust Multidrug Resistant Bacteria Eradication 2022 ·Advanced Healthcare Materials ·Jintao Fu, Ting Liu, Xiaoqian Feng, Yixian Zhou, Minglong Chen, Wenhao Wang, Yiting Zhao, Chao Lü, Guilan Quan, Jianfeng Cai, Xin Pan, Chuanbin Wu	31
11	A spark to the powder keg: Microneedle-based antitumor nanomedicine targeting reactive oxygen species accumulation for chemodynamic/photothermal/chemotherapy 2022 ·Journal of Colloid and Interface Science ·Kaixin Liao, Boyi Niu, (unknown), (unknown), Yixian Zhou, Ying Sun, Dan Yang, Chuanbin Wu, Xin Pan, Guilan Quan	19
12	Effective Photothermal Therapy Mediated by Indocyanine Green Nanoparticle Tip-Loaded Microneedles to Enhance Checkpoint Inhibitor Immunotherapy for Melanoma Treatment 2021 ·ACS Applied Nano Materials ·Peipei Yang, Minglong Chen, Wanbing Qin, (unknown), Xuequn Bai, Guilan Quan, Xin Pan, Chuanbin Wu	29
13	Recent advances in microneedles-mediated transdermal delivery of protein and peptide drugs 2021 ·Acta Pharmaceutica Sinica B ·(unknown), Minglong Chen, Jintao Fu, Ying Sun, Chao Lü, Guilan Quan, Xin Pan, Chuanbin Wu	85
14	A homogenous nanoporous pulmonary drug delivery system based on metal-organic frameworks with fine aerosolization performance and good compatibility 2020 ·Acta Pharmaceutica Sinica B ·Yixian Zhou, Boyi Niu, Biyuan Wu, (unknown), Jintao Fu, Yiting Zhao, Guilan Quan, Xin Pan, Chuanbin Wu	55
15	Poly(Ethylene Glycol) Crosslinked Multi-Armed Poly(l-Lysine) with Encapsulating Capacity and Antimicrobial Activity for the Potential Treatment of Infection-Involved Multifactorial Diseases 2020 ·Pharmaceutics ·Chao Lü, Ting Wen, (unknown), Daojun Liu, Guilan Quan, Xin Pan, Chuanbin Wu	20
16	Tailored core‒shell dual metal–organic frameworks as a versatile nanomotor for effective synergistic antitumor therapy 2020 ·Acta Pharmaceutica Sinica B ·Biyuan Wu, Jintao Fu, Yixian Zhou, (unknown), Yiting Zhao, Guilan Quan, Xin Pan, Chuanbin Wu	76
17	Molecular Architecture and Charging Effects Enhance the In Vitro and In Vivo Performance of Multi‐Arm Antimicrobial Agents Based on Star‐Shaped Poly(l‐lysine) 2019 ·Advanced Therapeutics ·Chao Lü, Guilan Quan, Ma Su, Alekhya Nimmagadda, Weidong Chen, Miao Pan, Peng Teng, (unknown), Xi Liu, (unknown), (unknown), Wei Hu, Fen Yao, Xin Pan, Chuanbin Wu, Daojun Liu, Jianfeng Cai	33
18	Fragmented particles containing octreotide acetate prepared by spray drying technique for dry powder inhalation 2018 ·Drug Delivery and Translational Research ·(unknown), Lu Li, Ying Huang, Vikramjeet Singh, Chune Zhu, Xin Pan, Guilan Quan, Chuanbin Wu	18
19	A novel scalable fabrication process for the production of dissolving microneedle arrays 2018 ·Drug Delivery and Translational Research ·(unknown), Biyuan Wu, Minmin Zhang, Peipei Yang, Beibei Yang, Wanbing Qin, Qingqing Wang, Xinguo Wen, Meiwan Chen, Guilan Quan, Xin Pan, Chuanbin Wu	40
20	The practical self-targeted oncolytic adenoviral nanosphere based on immuno-obstruction method via polyprotein surface precipitation technique enhances transfection efficiency for virotherapy 2018 ·Biochemical and Biophysical Research Communications ·Hao Ran, Guilan Quan, Ying Huang, Chune Zhu, Chao Lü, Weibin Liu, Xin Pan, Chuanbin Wu	5

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact